DASH

Dash Bio is a technology-first contract research organization (CRO) that specializes in automated clinical bioanalysis to accelerate drug development. Founded by former Moderna executives, the company leverages AI, robotics, and custom software to deliver high-quality assays with turnaround times up to 10 times faster than traditional industry standards. Dash Bio's platform supports a wide range of therapeutic modalities, including small molecules, biologics, and advanced therapies like mRNA and CRISPR. By providing rapid, GLP-compliant results in days rather than months, the company aims to eliminate operational bottlenecks in the clinical development phase. Dash Bio is headquartered in Waltham, Massachusetts, and operates a state-of-the-art automated laboratory facility.